6.18
price down icon0.16%   -0.01
after-market Dopo l'orario di chiusura: 6.18
loading
Precedente Chiudi:
$6.19
Aprire:
$6.23
Volume 24 ore:
159.33K
Relative Volume:
0.60
Capitalizzazione di mercato:
$235.07M
Reddito:
$239.40M
Utile/perdita netta:
$104.44M
Rapporto P/E:
2.0878
EPS:
2.96
Flusso di cassa netto:
$-18.50M
1 W Prestazione:
-8.98%
1M Prestazione:
+20.70%
6M Prestazione:
-21.37%
1 anno Prestazione:
-65.01%
Intervallo 1D:
Value
$6.13
$6.485
Intervallo di 1 settimana:
Value
$5.55
$6.80
Portata 52W:
Value
$4.93
$21.79

Entrada Therapeutics Inc Stock (TRDA) Company Profile

Name
Nome
Entrada Therapeutics Inc
Name
Telefono
857-305-1825
Name
Indirizzo
ONE DESIGN CENTER PLACE, BOSTON
Name
Dipendente
183
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-12
Name
Ultimi documenti SEC
Name
TRDA's Discussions on Twitter

Confronta TRDA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TRDA
Entrada Therapeutics Inc
6.18 230.50M 239.40M 104.44M -18.50M 2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.61 105.69B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.07 61.52B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.17 60.69B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
837.28 50.05B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.02 35.25B 4.56B -176.77M 225.30M -1.7177

Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-06 Iniziato ROTH MKM Buy
2024-01-05 Iniziato Oppenheimer Outperform
2023-04-03 Iniziato H.C. Wainwright Buy

Entrada Therapeutics Inc Borsa (TRDA) Ultime notizie

pulisher
Oct 16, 2025

Multi factor analysis applied to Entrada Therapeutics Inc.2025 Trading Volume Trends & High Accuracy Swing Entry Alerts - newser.com

Oct 16, 2025
pulisher
Oct 15, 2025

Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Applying sector rotation models to Entrada Therapeutics Inc.July 2025 Momentum & AI Enhanced Execution Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Sector ETF performance correlation with Entrada Therapeutics Inc.Portfolio Growth Summary & AI Driven Stock Reports - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What’s the recovery path for long term holders of Entrada Therapeutics Inc.Market Risk Summary & Expert Verified Movement Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Best data tools to analyze Entrada Therapeutics Inc. stockPortfolio Update Report & AI Enhanced Execution Alerts - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Is it time to cut losses on Entrada Therapeutics Inc.July 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com

Oct 15, 2025
pulisher
Oct 13, 2025

Technical analysis overview for Entrada Therapeutics Inc. stockChart Signals & High Conviction Buy Zone Picks - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

Signal strength of Entrada Therapeutics Inc. stock in tech scanners2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st

Oct 10, 2025
pulisher
Oct 10, 2025

Entrada Therapeutics (NASDAQ:TRDA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 09, 2025

H.C. Wainwright maintains $20 target on Entrada Therapeutics stock - MSN

Oct 09, 2025
pulisher
Oct 09, 2025

Entrada Therapeutics, Inc. (TRDA): Analyst Ratings Signal A 200% Upside Potential - DirectorsTalk Interviews

Oct 09, 2025
pulisher
Oct 07, 2025

Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Target Price at $25.67 - Defense World

Oct 07, 2025
pulisher
Oct 06, 2025

What’s next for Entrada Therapeutics Inc. stock priceStop Loss & Weekly Sector Rotation Insights - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

What high frequency data says about Entrada Therapeutics Inc.Weekly Trend Report & Daily Chart Pattern Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How to forecast Entrada Therapeutics Inc. trends using time series2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Can swing trading help recover from Entrada Therapeutics Inc. lossesTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Statistical indicators supporting Entrada Therapeutics Inc.’s strengthMarket Trend Summary & Growth Focused Entry Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Why Entrada Therapeutics Inc. stock is in analyst buy zone2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

Entrada Therapeutics Inc Stock Analysis and ForecastMarket Rumors and News & Free Trading Psychology Coaching - earlytimes.in

Sep 30, 2025
pulisher
Sep 29, 2025

What analysts say about Entrada Therapeutics Inc stockStochastic Oscillator Alerts & Exceptional Capital Trading - earlytimes.in

Sep 29, 2025

Entrada Therapeutics Inc Azioni (TRDA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Entrada Therapeutics Inc Azioni (TRDA) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
5AM Ventures V, L.P.
10% Owner
Jul 09 '25
Sale
7.50
20,065
150,528
3,163,066
5AM Ventures V, L.P.
10% Owner
Jul 09 '25
Sale
7.50
6,935
52,026
1,093,313
$21.97
price down icon 2.96%
$87.31
price down icon 0.95%
$32.75
price up icon 0.09%
$105.08
price up icon 0.71%
$163.19
price down icon 0.21%
biotechnology ONC
$318.02
price up icon 0.59%
Capitalizzazione:     |  Volume (24 ore):